These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4594319)

  • 61. [The outlook for an improvement in the agents for detection based on immunofluorescence analysis].
    Zlobin VN; Osin NS; Pomelova VG
    Vestn Ross Akad Med Nauk; 1999; (8):8-15. PubMed ID: 10487117
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Discussion about Management of In Vitro Diagnostic Reagent].
    Huang L; Zhu J; Gu H; Geng Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2015 Mar; 39(3):232-4. PubMed ID: 26524796
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Study on the supervision of in-vitro diagnostic reagents].
    Li H; Mu R; Ren H; Bai D
    Zhongguo Yi Liao Qi Xie Za Zhi; 2011 Jan; 35(1):68-70. PubMed ID: 21553542
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [First domestic production of transaminase assay reagents].
    Sugiyama S
    Yakushigaku Zasshi; 2003; 38(1):110-6. PubMed ID: 14570071
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Analysis on the Quality Status of in Vitro Diagnostic Reagents for National Medical Device Supervision and Inspection in 2020].
    Li X; Zhang X; Hao Q; Zhu J; Hong W
    Zhongguo Yi Liao Qi Xie Za Zhi; 2022 Jul; 46(4):459-463. PubMed ID: 35929166
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The assurance of analytical validity of results of cytological analysis: the requirements to reagents].
    Men'shikov VV
    Klin Lab Diagn; 2013 Apr; (4):53-4. PubMed ID: 23984560
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Is it possible to use the certified control materials in the accuracy evaluation of clinical laboratory examinations?].
    Aref'eva IA; Kondrasheva EA; Moshkin AV
    Klin Lab Diagn; 2005 May; (5):55-6. PubMed ID: 15986804
    [No Abstract]   [Full Text] [Related]  

  • 68. Methods for the preparation of standardized immunofluorescent reagents of increased specificities.
    Wickerhauser M; Pethtel BD
    Am J Clin Pathol; 1968 Nov; 50(5):575-81. PubMed ID: 4177312
    [No Abstract]   [Full Text] [Related]  

  • 69. The taming of immunohistochemistry: the new era of quality control.
    Herman GE; Elfont EA
    Biotech Histochem; 1991; 66(4):194-9. PubMed ID: 1912080
    [TBL] [Abstract][Full Text] [Related]  

  • 70. When antibodies mislead: the quest for validation.
    Baker M
    Nature; 2020 Sep; 585(7824):313-314. PubMed ID: 32895531
    [No Abstract]   [Full Text] [Related]  

  • 71. [Application of a new method for the calculation and description of the resistance of microbiological indicators. II. Establishment of and compliance with requirements for microbiological indicators (author's transl)].
    Spicher G; Peters J
    Zentralbl Bakteriol B; 1978 Nov; 167(4):347-61. PubMed ID: 735576
    [No Abstract]   [Full Text] [Related]  

  • 72. [The Situation and Countermeasures of the Undocumented in Vitro Diagnostic Reagents Urgently Needed in Clinical].
    Qiu M; Dong G; Xu X
    Zhongguo Yi Liao Qi Xie Za Zhi; 2015 Sep; 39(5):356-7, 366. PubMed ID: 26904881
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Letter: More information please about commercial reagents.
    Newman PF
    J Clin Pathol; 1976 Aug; 29(8):762. PubMed ID: 956459
    [No Abstract]   [Full Text] [Related]  

  • 74. Precise standardization of reagents for complement fixation.
    KENT JF; FIFE EH
    Am J Trop Med Hyg; 1963 Jan; 12():103-16. PubMed ID: 14031993
    [No Abstract]   [Full Text] [Related]  

  • 75. [Analysis of Cut Off Value or Reference Interval of
    Xu C; Liu R
    Zhongguo Yi Liao Qi Xie Za Zhi; 2021 Jun; 45(3):330-334. PubMed ID: 34096247
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Biological standardization in the international organization of WHO].
    GRASSET E
    Med Hyg (Geneve); 1952 May; 10(218):202-3. PubMed ID: 12992015
    [No Abstract]   [Full Text] [Related]  

  • 77. [The relationship between the problem of standardization and control of medical biological preparations and scientific-technical progress].
    Vopr Virusol; 1972; 17(4):500-1. PubMed ID: 5086863
    [No Abstract]   [Full Text] [Related]  

  • 78. [Standardiazation of thymol turbidity. I. Reliability of the preparation of basic turbidities using the methods of Shank-Hoagland and Boyd-Sommerville].
    Cicvárek Z; Hajzoková M
    Bratisl Lek Listy; 1968 Aug; 50(2):195-9. PubMed ID: 5685488
    [No Abstract]   [Full Text] [Related]  

  • 79. Opinion: Independent third-party entities as a model for validation of commercial antibodies.
    Laflamme C; Edwards AM; Bandrowski AE; McPherson PS
    N Biotechnol; 2021 Nov; 65():1-8. PubMed ID: 34246180
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Discussion on Strengthening the Hospital Management of in Vitro Diagnostic Reagents].
    Gu Z; Chen W; Wang Y; Zhao M
    Zhongguo Yi Liao Qi Xie Za Zhi; 2016 May; 40(3):227-9. PubMed ID: 29775268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.